Report: Cannabis Consumers Spending 25% More During Covid-19 Pandemic

1.3 min readPublished On: March 4th, 2021By
DENVER – Business intelligence from Akerna (Nasdaq: KERN), shows how the Covid-19 pandemic has altered daily lives of North Americans, with cannabis shoppers and patients spending about 25-30% more per purchase and are increasingly purchasing more volume of products per visit.
Over the past year (2020-2021), the average recreational cannabis purchase was $60 – climbing up from $48 in the previous year (2019-2020), with consumers’ basket size growing from an average of 2.25 products to 2.6. For medical purchasing, the average sale size is up to $123 per purchase, up from $100 in the previous year, and basket volume grew from 2.9 items to 3.02.

“This past year was a booming one for cannabis, even amid the economic crisis caused by the Covid-19 pandemic. The biggest change we see in our data is that patients are buying more products per visit, and it’s important for cannabis businesses to take these changes into mind when marketing their products,” said James Ahrendt, Business Intelligence Architect at Akerna. “With flower continuing to be the go-to product, brands should focus on differentiating their flower from the competition as well as education and benefits around other product categories.”

Additional Insights

Cannabis consumer shopping during the Covid-19 pandemic (2/1/2020 – 1/31/2021):

Average Order Sale (ticket):

  • Male (Rec) – $59.02
  • Male (Med) – $121.06
  • Female (Rec) – $64.50
  • Female (Med) – $125.22

Average basket size:

  • Male (Rec) – 2.48 items
  • Male (Med) – 2.93 items
  • Female (Rec) – 2.76 items
  • Female (Med) – 3.10 items

Gender Sales Market Share

  • Rec – Male 67% / Female 33%
  • Med – Male 61% / Female 39%

Age Group Sales Market Share:

  • Under 30 – 27%
  • 30 – 40 – 29%
  • 40 – 50 – 19%
  • 50 – 60 – 13%
  • 60+ – 12%

Category Sales Market Share:

  • Flower – 43%
  • Cartridges / Pens – 35%
  • Infused Edible – 8%
  • Concentrate – 12%
  • Non-Medicated – 1%
  • Infused Non-edible – 1%

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

ACS Laboratory Announces New THCOa Safety Bundle

January 19th, 2022|

BOCA RATON, Fla. - ACS Laboratory, hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other ...

Curaleaf Completes Acquisition of Bloom Dispensaries

January 19th, 2022|

WAKEFIELD, Mass. - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis, announced the completion of its previously announced acquisition of Bloom Dispensaries, a single state cannabis operator ...